Clinical trial
A Multicenter Clinical Study of the Sonablate® 500 (SB-500) for the Treatment of Localized (T1c/T2a) Prostate Cancer With HIFU
NCT00770822 is registered in ClinicalTrials.gov with SonaCare Medical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter Clinical Study of the Sonablate® 500 (SB-500) for the Treatment of Localized (T1c/T2a) Prostate Cancer With HIFU
- Lead sponsor
- SonaCare Medical
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 30, 2007
- Completion date
- December 31, 2020
- Enrollment
- 466 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer